Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Celecoxib Adjunct Treatment on Bipolar Disorder: Systematic Review and Meta-Analysis
Daniela Vicente Bavaresco, Tamy Colonetti, Antônio José Grande, et al.
CNS & Neurological Disorders - Drug Targets (2018) Vol. 18, Iss. 1, pp. 19-28
Closed Access | Times Cited: 24

Showing 24 citing articles:

Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets
Ana Catarina Pereira, Joana Oliveira, Sónia Silva, et al.
Pharmacological Research (2020) Vol. 163, pp. 105325-105325
Closed Access | Times Cited: 63
Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Adam Gędek, Zofia Szular, Anna Antosik-Wójcińska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3497-3497
Open Access | Times Cited: 20
Effect of celecoxib on improving depression: A systematic review and meta-analysis
Zhi Wang, Qiao Wu, Qīng Wáng
World Journal of Clinical Cases (2022) Vol. 10, Iss. 22, pp. 7872-7882
Open Access | Times Cited: 21
rTMS ameliorates CUMS-induced anxiety-depression-like behaviour and cognitive dysfunction in rats by modulating the COX-2/PGE2 signalling pathway
Yanjiao Pei, Huanhuan Liu, Jiqing Lang, et al.
Journal of Psychiatric Research (2025)
Closed Access
Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study
Marta Garés-Caballer, Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 18
Therapeutic potential of COX-2 inhibitors in neuropsychiatric disorders
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Journal of Neural Transmission (2025)
Closed Access
Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: A case-control study
Daniela Vicente Bavaresco, Maria Inês da Rosa, Maria Laura Rodrigues Uggioni, et al.
Journal of Affective Disorders (2020) Vol. 271, pp. 115-122
Closed Access | Times Cited: 20
Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases
Neetu Rani, Aastha Kaushik, Shefali Kardam, et al.
Progress in molecular biology and translational science (2024), pp. 23-70
Closed Access | Times Cited: 2
Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran
Farhad Farıdhosseını, Ali Talaeı, Najmeh Shahini, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 5, pp. 336-341
Closed Access | Times Cited: 6
Adjunctive dietary intervention for bipolar disorder: a randomized, controlled, parallel‐group, modified double‐blinded trial of a high n‐3 plus low n‐6 diet
Erika F.H. Saunders, Dahlia Mukherjee, Tiffany Jo Myers, et al.
Bipolar Disorders (2021) Vol. 24, Iss. 2, pp. 171-184
Open Access | Times Cited: 14
Mitochondrial Dysfunction in Blood Platelets of Patients with Manic Episode of Bipolar Disorder
Jana Hroudová, Zdeněk Fišar, Hana Hansíková, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 3, pp. 222-231
Closed Access | Times Cited: 15
Neuropsychiatric disorders: An immunological perspective
Ernest Aw, Yingying Zhang, Esra Yalçın, et al.
Advances in immunology (2021), pp. 83-155
Closed Access | Times Cited: 12
Efficacy and safety of celecoxib monotherapy for treatment of moderate depressive symptoms following COVID-19 infection: A randomized, double-blind, placebo-controlled trial
Sahar Ansari, Hossein Sanjari Moghaddam, Fatemeh A. Basti, et al.
Journal of Psychosomatic Research (2023) Vol. 174, pp. 111471-111471
Closed Access | Times Cited: 4
Changes in Non-Coding RNA in Depression and Bipolar Disorder: Can They Be Used as Diagnostic or Theranostic Biomarkers?
Andrew S. Gibbons, Suresh Sundram, Brian Dean
Non-Coding RNA (2020) Vol. 6, Iss. 3, pp. 33-33
Open Access | Times Cited: 10
The future of immunopsychiatry: Three milestones to clinical innovation
Livia De Picker
Brain Behavior & Immunity - Health (2021) Vol. 16, pp. 100314-100314
Open Access | Times Cited: 9
Characterization of Carbonic Anhydrase In Vivo Using Magnetic Resonance Spectroscopy
Jyoti Tomar, Jun Shen
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2442-2442
Open Access | Times Cited: 9
THERAPEUTIC TARGETING OF BRAIN ARACHIDONIC ACID CASCADE IN BIPOLAR DISORDER BY LOW DOSE ASPIRIN AND CELECOXIB
Stanley I. Rapoport, Joseph R. Hibbeln
Prostaglandins Leukotrienes and Essential Fatty Acids (2020) Vol. 159, pp. 102118-102118
Closed Access | Times Cited: 9
Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients
Stephen Murata, Nausheen Baig, Kyle Decker, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1408-1408
Open Access | Times Cited: 3
Evaluation of the arachidonic acid pathway in bipolar disorder: a systematic review
Daniela Vicente Bavaresco, Maria Laura Rodrigues Uggioni, Carla Sasso Simon, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 10, pp. 8209-8217
Closed Access | Times Cited: 7
New Pharmacological Interventions in Bipolar Disorder
Mário F. Juruena, Luke A. Jelen, Allan H. Young, et al.
Current topics in behavioral neurosciences (2020), pp. 303-324
Closed Access | Times Cited: 6
Aspirin and celecoxib may help to rectify a neurotransmission imbalance in bipolar disorder
Stanley I. Rapoport
Medical Hypotheses (2021) Vol. 149, pp. 110536-110536
Open Access | Times Cited: 6
The role of ncRNAs in depression
Xinchi Luan, Xing Han, Feifei Guo, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27307-e27307
Open Access
Neuroimmune pathways in bipolar disorder
Izabela Guimarães Barbosa, Moisés Evandro Bauer, Antônio Lúcio Teixeira
Elsevier eBooks (2022), pp. 191-214
Closed Access | Times Cited: 1
The Role of Ncrnas in Depression
Xinchi Luan, Xing Han, Feifei Guo, et al.
(2023)
Closed Access
Analgetika

Elsevier eBooks (2022), pp. 511-774
Closed Access
Page 1

Scroll to top